Previous close | 2.3500 |
Open | 2.3700 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 2.1300 - 2.4500 |
52-week range | 0.7500 - 5.8800 |
Volume | |
Avg. volume | 92,557 |
Market cap | 7.912M |
Beta (5Y monthly) | 1.77 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.7000 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Universe Pharmaceuticals INC ("Universe Pharmaceuticals" or the "Company") (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its financial results for the fiscal year ended September 30, 2023.
Universe Pharmaceuticals INC ( NASDAQ:UPC ) shareholders would be excited to see that the share price has had a great...
Jiangxi, China, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on August 1, 2023, notifying the Company that it is not in compliance with the minimum Market Value of Publicly Held Shares (“MVPHS”) requirement set forth in the Nasdaq L